Skip to main content

Table 1 Characteristics of the total study population and individuals with and without the Metabolic Syndrome

From: Age- and sex-specific prevalence and ten-year risk for cardiovascular disease of all 16 risk factor combinations of the metabolic syndrome - A cross-sectional study

Risk factor/Trait All
(n = 35,869)
Without MetS*
(n = 25,961)
With MetS*
(n = 7,122)
  Men Women Men Women Men Women
N (%) 13,942 (38.9) 21,927 (61.1) 9,452 (36.4) 16,509 (63.6) 3,168 (44.5) 3,954 (55.5)
Age (years), mean ± SD 53.0 ± 15.8 50.9 ± 16.2 50.9 ± 16.3 48.1 ± 15.9 58.8 ± 12.9 60.5 ± 13.9
Weight (kg), mean (±SD) 86.2 ± 14.9 71.9 ± 15.2 81.7 ± 12.2 68.3 ± 13.1 97.1 ± 15.3 84.5 ± 15.9
Body Mass Index (%)       
   ≤25 kg/m2 29.7 46.4 40.4 57.9 4.3 8.0
   25 - <30 kg/m2 45.6 30.3 47.7 28.9 38.6 33.1
   ≥30 kg/m2 24.7 23.3 11.9 13.1 57.1 58.9
Waist circumference (cm), mean ± SD 98.8 ± 13.0 86.8 ± 14.3 94.1 ± 10.9 82.5 ± 12.0 110.4 ± 10.7 101.6 ± 11.8
Blood parameters       
   Blood glucose (mmol/l), mean ± SD 5.7 ± 2.0 5.3 ± 1.6 5.2 ± 1.4 4.9 ± 0.9 7.1 ± 2.9 6.7 ± 2.6
   Total Cholesterol (mmol/l), mean ± SD 5.3 ± 1.1 5.4 ± 1.1 5.2 ± 1.0 5.3 ± 1.0 5.3 ± 1.2 5.6 ± 1.1
   HDL (mmol/l), mean ± SD 1.4 ± 0.4 1.7 ± 0.4 1.5 ± 0.4 1.8 ± 0.4 1.2 ± 0.3 1.4 ± 0.4
   LDL (mmol/l), mean ± SD 3.3 ± 0.9 3.3 ± 0.9 3.3 ± 0.9 3.2 ± 0.9 3.3 ± 1.0 3.5 ± 1.0
   Triglycerides (mmol/l), median(Q1; Q3) 1.6 (1.1;2.4) 1.3 (0.9;1.9) 1.4 (1.0;1.9) 1.2 (0.9;1.5) 2.4 (1.7;3.4) 2.1 (1.6;2.9)
Blood Pressure (BP)       
   Systolic BP (mmHg), mean ± SD 133.6 ± 18.2 128.5 ± 19.3 129.9 ± 17.4 124.4 ± 17.9 142.7 ± 16.8 142.7 ± 17.5
   Diastolic BP (mmHg), mean ± SD 81.4 ± 10.4 79.2 ± 10.6 79.9 ± 10.0 77.6 ± 10.2 84.9 ± 10.5 84.5 ± 10.4
Smoking status (%)       
   Current Smoker 27.5 23.5 28.7 24.6 23.7 18.9
   Past Smoker 39.8 22.3 35.4 22.4 50.3 21.6
   Never Smoker 32.8 54.2 35.9 53.0 26.0 59.5
MetS Traits (%)       
   WC 36.4 41.5 17.1 26.3 84.1 92.8
   TG 24.0 12.9 12.1 4.6 63.7 53.4
   HDL 12.2 13.9 4.6 5.6 32.8 46.8
   BP 66.6 52.9 55.8 41.8 92.5 91.6
   GL 29.5 17.6 13.1 5.3 75.6 68.1
Pharmacotherapy (%)       
   Anti-diabetic 12.0 7.0 4.9 1.6 34.2 30.1
   Anti-hypertensive 41.7 34.2 32.3 25.0 67.3 67.8
   Lipid lowering 18.1 10.5 14.0 6.9 29.5 24.6
Comorbidities (%)       
   Cardiovascular diseases 20.5 10.5 16.5 7.2 31.7 22.9
   Cancer 5.5 4.9 5.2 4.3 6.7 7.1
  1. *Of n = 2,768 subjects MetS was not definable because of missing traits
  2. MetS, Metabolic Syndrome (for cut points used see methods); BMI, Body Mass Index; SD, Standard Deviation; HDL, High Density Lipoprotein; LDL, Low Density Lipoprotein; BP, Blood Pressure; WC, waist circumference; TG, triglyceride; BP, blood pressure; GL, blood glucose